
Péptidos
Los péptidos son cadenas cortas de aminoácidos unidas por enlaces peptídicos, que desempeñan papeles importantes como moléculas biológicas en los procesos celulares. Funcionan como hormonas, neurotransmisores y moléculas de señalización, y se utilizan ampliamente en aplicaciones terapéuticas y diagnósticas. Los péptidos también son cruciales en la investigación para estudiar las interacciones de proteínas, actividades enzimáticas y vías de señalización celular. En CymitQuimica, ofrecemos una amplia selección de péptidos de alta calidad para apoyar sus necesidades de investigación y desarrollo en biotecnología y farmacéutica.
Subcategorías de "Péptidos"
Productos de "Péptidos"
Ordenar por
Ac-VLRLRGG-CHO
Peptide Ac-VLRLRGG-CHO is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-VLRLRGG-CHO include the following: Towards deep-sea toxicology: Experimental approaches with echinoderms SJM Hughes - 2010 - eprints.soton.ac.ukhttps://eprints.soton.ac.uk/168893/1/Hughes_SJM_2010_Towards_ecotoxicology_experimental_approaches_with_echinoderms_PhD_Thesis_SOES_University_of_Southampton.pdf BRCA1 is a histone-H2A-specific ubiquitin ligase R Kalb, DL Mallery , C Larkin, JTJ Huang , K Hiom - Cell reports, 2014 - cell.comhttps://www.cell.com/cell-reports/pdf/S2211-1247(14)00609-3.pdf Ion mobility, hydrogen/deuterium exchange, and isotope scrambling: Tools to aid compound identification in 'omics mixtures H Maleki, MM Maurer , N Ronaghi - Analytical , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.analchem.7b00075 Specificity of the E1-E2-E3 enzymatic cascade for ubiquitin C-terminal sequences identified by phage display B Zhao, K Bhuripanyo, J Schneider , K Zhang - ACS chemical , 2012 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/cb300339pAc-RRCPLYISYDPVCRR-NH2
Peptide Ac-RRCPLYISYDPVCRR-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-RRCPLYISYDPVCRR-NH2 include the following: treatment of insomnia Menu K Sakamoto, Y Kamada, T Sameshima, M Yaguchi - az960antagonist.comhttps://az960antagonist.com/lilr5/krpep-2d/ Overcoming resistance to drugs targeting KRASG12C mutation D Jiao, S Yang - The Innovation, 2020 - cell.comhttps://www.cell.com/the-innovation/pdf/S2666-6758(20)30035-7.pdfH-QEGPEYWEEQTQRAK-OH
Peptide H-QEGPEYWEEQTQRAK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-QEGPEYWEEQTQRAK-OH include the following: Targeting MHC class I monomers to dendritic cells inhibits the indirect pathway of allorecognition and the production of IgG alloantibodies leading to long-term Y Tanriver, K Ratnasothy, RP Bucy - The journal of , 2010 - journals.aai.orghttps://journals.aai.org/jimmunol/article/184/4/1757/38775 Transplantation tolerance modifies donor-specific B cell fate to suppress de novo alloreactive B cells SHW Khiew , D Jain , J Chen , J Yang - The Journal of , 2020 - Am Soc Clin Investighttps://www.jci.org/articles/view/132814 Alloimmunogenicity of an isolated MHC allele is affected by the context of MHC mismatch in a murine model KE Hudson , ASL Wong, AL Richards, LM Kapp - , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/trf.15109 HETEROGENEITY OF T CELL CLONES SPECIFIC FOR A SINGLE INDIRECT ALLOANTIGENIC EPITOPE (I-Ab/H-2Kd54-68) THAT MEDIATE TRANSPLANT K Honjo, X yan Xu, RP Bucy - Transplantation, 2000 - journals.lww.comhttps://journals.lww.com/transplantjournal/fulltext/2000/11270/heterogeneity_of_t_cell_clones_specific_for_a.20.aspx Indefinite mouse heart allograft survival in recipient treated with CD4+ CD25+ regulatory T cells with indirect allospecificity and short term immunosuppression JYS Tsang, Y Tanriver, S Jiang, E Leung - Transplant , 2009 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0966327409000458 Targeting MHC Class I Monomers to G Lombardi, R Lechler, Y Tanriver, K Ratnasothy - 2010 - researchgate.nethttps://www.researchgate.net/profile/Yakup-Tanriver-2/publication/41056285_Targeting_MHC_Class_I_Monomers_to_Dendritic_Cells_Inhibits_the_Indirect_Pathway_of_Allorecognition_and_the_Production_of_IgG_Alloantibodies_Leading_to_Long-Term_Allograft_Survival/links/5ea9239c45851592d6a85ea9/Targeting-MHC-Class-I-Monomers-to-Dendritic-Cells-Inhibits-the-Indirect-Pathway-of-Allorecognition-and-the-Production-of-IgG-Alloantibodies-Leading-to-Long-Term-Allograft-Survival.pdfASCL4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ASCL4 antibody, catalog no. 70R-9025Pureza:Min. 95%ACER1 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of ACER1 antibody, catalog no. 70R-10188Pureza:Min. 95%H-SGGGDLTLGLEPSEEEAPR^-OH
Peptide H-SGGGDLTLGLEPSEEEAPR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-SGGGDLTLGLEPSEEEAPR^-OH include the following: Targeted proteomics for validation of biomarkers in clinical samples X Ye, J Blonder , TD Veenstra - Briefings in Functional Genomics , 2009 - academic.oup.comhttps://academic.oup.com/bfg/article-abstract/8/2/126/200832 Analysis of biofluids for biomarker research X Xu, TD Veenstra - PROTEOMICS-Clinical Applications, 2008 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/prca.200780173 The addition of FAIMS increases targeted proteomics sensitivity from FFPE tumor biopsies S Sweet , D Chain, W Yu, P Martin, M Rebelatto - Scientific Reports, 2022 - nature.comhttps://www.nature.com/articles/s41598-022-16358-1 High-Field Asymmetric Waveform Ion Mobility Spectrometry and Parallel Reaction Monitoring Increases Sensitivity for Clinical Biomarker Quantitation from Formalin S Sweet , D Chain, W Yu, P Martin, M Rebelatto - bioRxiv, 2022 - biorxiv.orghttps://www.biorxiv.org/content/10.1101/2022.02.08.479554.abstract Challenges Remain in MS-Based Proteomic Analysis of Complex Biological Samples PF Dimond - Clinical OMICs, 2014 - liebertpub.comhttps://www.liebertpub.com/doi/full/10.1089/clinomi.01.12.06H-RRETQL-OH
Peptide H-RRETQL-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RRETQL-OH include the following: Computational Analysis of Domains Vulnerable to HPV-16 E6 Oncoprotein and Corresponding Hot Spot Residues RM Malik, S Fazal, MA Kamal - Protein and Peptide Letters, 2021 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/ppl/2021/00000028/00000004/art00008 Additive energetic contributions of multiple peptide positions determine the relative promiscuity of viral and human sequences for PDZ domain targets EF Tahti, JM Blount, SN Jackson, M Gao - Protein , 2023 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/pro.4611 Combining T-cell vaccination and application of agonistic anti-GITR mAb (DTA-1) induces complete eradication of HPV oncogene expressing tumors in mice C Hoffmann, J Stanke, AM Kaufmann - Journal of , 2010 - journals.lww.comhttps://journals.lww.com/immunotherapy-journal/fulltext/2010/02000/Phase_I_Trial_of_Vaccination_With_Autologous.3.aspxSH3BP2 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SH3BP2 antibody, catalog no. 70R-5805Pureza:Min. 95%H-LPDATPK-OH
Peptide H-LPDATPK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-LPDATPK-OH include the following: Investigation of the protective effect for GcMAF by a glycosidase inhibitor and the glycan structure of Gc protein Y Kanie, Y Maegawa, Y Wei, O Kanie - Molecules, 2023 - mdpi.comhttps://www.mdpi.com/1420-3049/28/4/1570 The influence of proteoforms: assessing the accuracy of total vitamin D-binding protein quantification by proteolysis and LC-MS/MS LE Kilpatrick, R Bouillon, WC Davis - Clinical Chemistry and , 2023 - degruyter.comhttps://www.degruyter.com/document/doi/10.1515/cclm-2022-0642/html Quantification of total vitamin-D-binding protein and the glycosylated isoforms by liquid chromatography-isotope dilution mass spectrometry LE Kilpatrick, KW Phinney - Journal of Proteome Research, 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.jproteome.7b00560 Phenotyping and relative quantification of vitamin D binding protein in a paediatric population by using liquid chromatography-tandem mass spectrometry AI Cillero, E MartacaÂnez-Morillo - Annals of Clinical , 2019 - journals.sagepub.comhttps://journals.sagepub.com/doi/abs/10.1177/0004563218780135N-(tert-Butoxycarbonyl)-4-fluoro-D-phenylalanine
CAS:Fórmula:C14H18FNO4Pureza:>98.0%(T)Forma y color:White to Almost white powder to crystalPeso molecular:283.30H-RRARSLSAERY-OH
Peptide H-RRARSLSAERY-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-RRARSLSAERY-OH include the following: Immunodominance among EBV-derived epitopes restricted by HLA-B27 does not correlate with epitope abundance in EBV-transformed B-lymphoblastoid cell lines VL Crotzer, RE Christian, JM Brooks - The Journal of , 2000 - journals.aai.orghttps://journals.aai.org/jimmunol/article/164/12/6120/33089 The relationship between the cell surface density and the immunogenicity of multiple Epstein-Barr virus epitopes VL Crotzer - 2000 - search.proquest.comhttps://search.proquest.com/openview/06a0758b23e4b23671968815a6781078/1?pq-origsite=gscholar&cbl=18750&diss=y The adaptive immune response to Epstein-Barr virus M Rist - 2015 - core.ac.ukhttps://core.ac.uk/download/pdf/43375821.pdf HLA-B27 subtype polymorphism and CTL epitope choice: studies with EBV peptides link immunogenicity with stability of the B27: peptide complex JM Brooks , RA Colbert , JP Mear, AM Leese - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/161/10/5252/31819Liver-Cell Growth Factor
CAS:Producto controladoLiver-Cell Growth Factor (LCGF) is a growth factor that stimulates the proliferation of liver cells. LCGF is found in coagulation factors, fatty acids, and peptides. LCGF has been shown to have long-term efficacy in the treatment of liver disease and has been demonstrated to be neuroprotective in animal models of Parkinson's disease. This growth factor also inhibits nucleotidase, which is an enzyme that breaks down nucleotides into mononucleotides and diphosphates. LCGF has been associated with statistically significant improvements in diameter and lysine levels in fetal bovine serum.Fórmula:C14H24N6O4•CH3COOH•H2OPureza:Min. 95%Peso molecular:418.45 g/molSLC39A4 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of SLC39A4 antibody, catalog no. 70R-6695Pureza:Min. 95%H-TRATKMQVI-OH
Peptide H-TRATKMQVI-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-TRATKMQVI-OH include the following: Ex vivo functional analysis, expansion and adoptive transfer of cytomegalovirus-specific T-cells in patients with glioblastoma multiforme T Crough, L Beagley, C Smith , L Jones - Immunology and cell , 2012 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1038/icb.2012.19 Immunological prediction of cytomegalovirus (CMV) replication risk in solid organ transplantation recipients: approaches for regulating the targeted anti-CMV SH Han - Infection & chemotherapy, 2017 - ncbi.nlm.nih.govhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620383/ MHC class I and class II reactivity mediated by a single T cell receptor S Eckle, S Gras , L Kjer-Nielsen, C Smith - A: Foundations of , 2011 - scripts.iucr.orghttps://scripts.iucr.org/cgi-bin/paper?S0108767311086260 Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates S Cantisan, C Rodelo-Haad, A Paez-Vega - American Journal of , 2015 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1600613522001332 Comparisons of CD8+ T Cells Specific for Human Immunodeficiency Virus, Hepatitis C Virus, and Cytomegalovirus Reveal Differences in Frequency P Jagannathan , CM Osborne, C Royce - Journal of , 2009 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02128-08 Computational design of a legacy-based epitope vaccine against Human Cytomegalovirus MJ Quinzo, EM Lafuente , DR Flower - on Bioinformatics and , 2018 - ieeexplore.ieee.orghttps://ieeexplore.ieee.org/abstract/document/8621537/ Cross-recognition of HLA DR4 alloantigen by virus-specific CD8+ T cells: a new paradigm for self-/nonself-recognition M Rist, C Smith , MJ Bell, SR Burrows - Blood, The Journal of , 2009 - ashpublications.orghttps://ashpublications.org/blood/article-abstract/114/11/2244/25832 Use of peptides and peptide libraries as T-cell stimulants in flow cytometric studies G Cherepnev, HD Volk , F Kern - Methods in cell biology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0091679X04750189Epidermal Mitosis Inhibiting Pentapeptide
Catalogue peptide; min. 95% purityFórmula:C19H27N5O12Peso molecular:517.45 g/molFBXO34 Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of FBXO34 antibody, catalog no. 70R-3482Pureza:Min. 95%L-Ornithine Dihydrochloride
CAS:Fórmula:C5H12N2O2·2HClPureza:>98.0%(N)Forma y color:White to Almost white powder to crystalPeso molecular:205.08Crystallin α B Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of CRYAB antibody, catalog no. 70R-1016Pureza:Min. 95%1-Acetyl-5-bromo-6-chloro-1H-indol-3-ol
CAS:Please enquire for more information about 1-Acetyl-5-bromo-6-chloro-1H-indol-3-ol including the price, delivery time and more detailed product information at the technical inquiry form on this pageFórmula:C10H7BrClNO2Pureza:Min. 95 Area-%Forma y color:PowderPeso molecular:288.52 g/molPOLB Blocking Peptide
A synthetic peptide for use as a blocking control in assays to test for specificity of POLB antibody, catalog no. 70R-5581Pureza:Min. 95%